Forever young: the business of longevity drugs

The Intelligence from The Economist23 minuten

Speel aflevering af

Over de aflevering

The success of GLP-1s has prompted biotechs to approach the challenge differently. After years of false starts and disappointing results, longevity drugs could be on the horizon. Do immigrants from some countries commit more sex crimes? And the big business of miniatures.

Guests and host:

Shailesh Chitnis, global business writer

James Fransham, data correspondent

Sascha Lowdermilk, culture intern

Ọrẹ Ogunbiyi, co-host of “The Intelligence”

Topics covered:

Longevity drugs, biotechnology, ageing

Immigration, sex crime, Britain

Miniatures, 3D printing, hobbies

Listen to what matters most, from global politics and business to science and technology—subscribe to The Economist.

Hosted on Acast. See acast.com/privacy for more information.


Meer The Intelligence from The Economist

Alle afleveringen